Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
11/2003
11/26/2003CN1128628C Chinese medicine for treating alopecia areata
11/26/2003CN1128623C Instant effervescent particles for Ca-supplementing health-care products and its preparing process
11/25/2003US6653354 Administering to the mammal xenon to modulate the activity of NMDA (N-methyl-D-aspartate) receptor, and a GABAergic agent, (sedative or anesthetics) thus preventing synaptic plasticity or relieving neuropathic pain
11/25/2003US6652840 Aluminum chloride, ferric sulfate, regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and solvent; easy to use; reducing heart rate stimulation, staining, acid irritations and adhesive interference
11/25/2003US6652479 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
11/25/2003CA2180506C Inhalation of nitrogen monoxide for the prevention and the treatment of inflammatory reactions
11/20/2003WO2003095436A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use
11/20/2003WO2003095085A1 Colloidal dispersion of calcium phosphate nanoparticles and at least one protein, and corresponding redispersible and calcined nanoparticles, preparation method and uses
11/20/2003WO2003094984A1 Bone outgrowth agent and therapeutic agent for osteoporosis
11/20/2003WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/20/2003WO2003094934A1 Medicine for prevention of and treatment for amyloidosis
11/20/2003WO2003094933A2 Use of lanthanum for the treatment of hypercalcemia and bone metastasis
11/20/2003WO2003094932A1 Carbon monoxide as a biomarker and therapeutic agent
11/20/2003WO2003094922A1 Use of cisplatin in combination with folic acid for increasing cisplatin efficacy
11/20/2003WO2003094902A2 Surface treatment of sars-infected lungs
11/20/2003WO2003094881A1 Composition and the use thereof as a pharmaceutical or cosmetic formulation for external use
11/20/2003WO2003007970A3 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement
11/20/2003WO2002100420A3 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne
11/20/2003US20030216777 Method of enhancing healing of interfacial gap between bone and tendon or ligament
11/20/2003US20030216377 Vitronectin receptor antagonist
11/20/2003US20030216359 Administering vitamin D or a derivative and a cytotoxic agent or a glucocorticoid and, optionally, a bisphosphonate
11/20/2003US20030216348 Aminosugar, glycosaminoglycan, and S-Adenosylmethionine composition for the treatment and repair of connective tissue
11/20/2003US20030215528 Prophylaxis and prevention of cancer, tumors, hyperplasia, hypertrophy or dysplasia comprising administering nitrates such as nitroglycerin; angiogenesis inhibitors
11/20/2003US20030215527 Novel substituted benzimidazole dosage forms and method of using same
11/20/2003US20030215526 Stable formulations of angiotensin converting enzyme (ACE) inhibitors
11/20/2003US20030215525 Heat treated suspensions comprising group III compounds, preservatives, antideposit agents and optionally adjuvants, used for prophylaxis of gastrointestinal disorders
11/20/2003US20030215524 Stable pharmaceutical composition useful for treating gastrointestinal disorders
11/20/2003US20030215522 Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
11/20/2003US20030215521 Plastic containers, plates, films or fibers, having group IB compounds such as silver zirconium phosphate as microbiocides
11/20/2003US20030215520 Generation of ozone and oxygen from air, then flowing the gas mixture into water using a venturi; water treatment
11/20/2003US20030215491 Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane
11/20/2003US20030215404 Composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting
11/20/2003US20030215401 Potassium or strontium salt as a nerve desensitizing agent; tubule blocking agent, that may be a hydrolyzed long-chain olefin-maleic anhydride copolymer
11/20/2003US20030215388 Can be administered in conjunction with radiation or chemotherapeutic agents.
11/20/2003US20030213937 Precipitated aragonite and a process for producing it
11/20/2003CA2511749A1 Surface treatment of sars-infected lung
11/20/2003CA2484770A1 Carbon monoxide as a biomarker and therapeutic agent
11/19/2003EP1362885A1 Antimicrobially treated material and methods of preventing coloring thereof
11/19/2003EP1362598A1 Active oxygen generator containing photosensitizer for ultrasonic therapy
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP0914111B1 Prevention and treatment of cachexia and anorexia
11/19/2003CN1457261A Method and compositions for prevention or treatment of cancer
11/19/2003CN1456338A Medicine for treating diabets mellitus
11/19/2003CN1456333A Capsules against thrombus and preparation thereof
11/19/2003CN1456313A Tiegudan for ischemic necrosis of fernoral head
11/19/2003CN1456217A Medicine for curing choleithiasis and preparing method thereof
11/19/2003CN1456172A Healthy vitamin nutrient solution
11/19/2003CN1456171A Compound electrolyte intra-ocular flushing liquor
11/19/2003CN1127976C Exterior-applied Chinese-medicinal pill for treatnig diarrhea
11/19/2003CN1127974C Chinese medicinal preparation for fracture
11/19/2003CN1127970C Ointment for treating burn and its preparing process
11/19/2003CN1127967C Capsules for hypertension and their preparation
11/19/2003CN1127964C Chinese medicine for treating dermatopathy (leukoderma and psoriasis)
11/19/2003CN1127962C Capsule for curing hydrocephalus and its producing method
11/19/2003CN1127961C Exterior-applied medicine for treatnig dermatopathy and its preparing process
11/19/2003CN1127960C Eyesight improving medicine liquid
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649195 Eyesight enhanced maintenance composition
11/18/2003US6649193 Biomedically acceptable, cage-like compounds, including cobalamin (vitamin B12), potassium silicate and colloidal silicates and aluminosilicates such as zeolites encage atomic hydrogen in a
11/18/2003US6649179 A plasminogen activator inhibitor comprising zinc oxide which adsorbs a plasminogen activator and inhibits its activity, thus improving rough skin
11/18/2003US6649147 Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/18/2003US6649145 Wound healing, treating infections
11/13/2003WO2003093478A1 Immunoconjugates for the treatment of tumours
11/13/2003WO2003093322A2 Carrageenan based antimicrobial compositions
11/13/2003WO2003092763A1 Carbon nanotubules for storage of nitric oxide
11/13/2003WO2003092730A1 Hydroxycitric acid salt composition and method of making
11/13/2003WO2003092707A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
11/13/2003WO2003092703A1 Methods and compositions for inhibition or irritation by disaccharide and metal ions
11/13/2003WO2003092691A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003WO2003092674A1 Prenatal multivitamin/multimineral supplement
11/13/2003WO2003092647A2 Transport system in biological systems
11/13/2003WO2003092613A2 Catechin multimers as therapeutic drug delivery agents
11/13/2003WO2003092589A2 Salt solution for colon cleansing
11/13/2003WO2003092468A2 Biomatrix structural containment and fixation systems and methods of use thereof
11/13/2003WO2003061588A3 Method of increasing fertility and athletic performance in horses
11/13/2003WO2003020262A3 Use of polyunsaturated fatty acids for intra-arterial injection for selectively occluding blood supplies to neoplasias
11/13/2003WO2003000065A3 Tooth whitening chewing gum
11/13/2003WO2002062354A8 Allergen neutralization compositions containing aluminum ions
11/13/2003WO2002018278A8 Method and apparatus for preparing aqueous dispersion of ultra-fine active carbon particles
11/13/2003WO2002013826A9 Anti-cancer composition composed of anti-cancer and anti-malarial drugs
11/13/2003US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
11/13/2003US20030211607 Antisense modulation of survivin expression
11/13/2003US20030211210 Using 1,3-dibromo-5,5-dimethylhydantoin in aqueous solution
11/13/2003US20030211173 Lubrication composition
11/13/2003US20030211172 Composition and method for substantially reducing the deleterious effects of alcohol on the body
11/13/2003US20030211171 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
11/13/2003US20030211170 Wound healing agents
11/13/2003US20030211133 Mixture of methylcobalamin and vitamin b
11/13/2003US20030211132 Method for reducing radioactivity in the human body
11/13/2003CA2484312A1 Catechin multimers as therapeutic drug delivery agents
11/13/2003CA2484303A1 Salt solution for colon cleansing
11/13/2003CA2483785A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003CA2483778A1 Biomatrix structural containment and fixation systems and methods of use thereof
11/13/2003CA2462879A1 Immunoconjugates for the treatment of tumours
11/12/2003EP1360957A1 Vitamin/mineral complex
11/12/2003EP1360508A2 Prediction of wound healing by urinary nitrate assay
11/12/2003EP1359923A1 Use of selenite or preparations containing selenite for treating wounds
11/12/2003EP0999819B1 Physiological combination of active substances to enhance the skin's defenses against noxious agents